GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

A systems analysis of drug tolerance in Mycobacterium tuberculosis

$886,311
Nitin S Baliga · Institute For Systems Biology · R01 · FY2023 · AI

Rapid phage-amplified immunoassay for phenotypic UTI diagnosis and antimicrobial susceptibility testing

$886,085
Christopher R Cox · Cobio Diagnostics Inc. · R44 · FY2023 · DK

Molecular mechanisms of immune evasion in Staphylococcus aureus

$885,966
Michael Otto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Rapid detection of pathogens and antimicrobial susceptibility directly in patient samples

$885,378
Sadanand Gite · First Light Diagnostics , Inc. · R01 · FY2018 · AI

In Vitro Core

$885,209
Michael A Hoffman · University Of Wisconsin-Madison · U19 · FY2014 · AI

Molecular mechanisms of immune evasion in Staphylococcus aureus

$884,987
Michael Otto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

O-polysaccharide (OPS)-IpaB Conjugate Vaccine to Prevent Shigellosis

$884,638
Marcela F Pasetti · University Of Maryland Baltimore · R01 · FY2024 · AI

Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens

$884,388
Daniel E Kahne · Harvard Medical School · U19 · FY2018 · AI

A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women

$883,902
David J. Margolis · University Of Pennsylvania · U01 · FY2024 · AR

Targeting bacterial cell wall biogenesis for the development of novel antimicrob

$882,519
Thomas G Bernhardt · Harvard Medical School · U19 · FY2018 · AI

Optimizing Inhibitors of T. gondii ENR

$881,657
Rima L McLeod · University Of Chicago · U01 · FY2010 · AI

RNA: New Antimicrobial Strategies

$881,227
Adrian Ferre-D'amare · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL

Innate, Transcriptomic, and Microbiomic correlates of TB infection

$880,842
Michael Haggai Glickman · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI

Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms

$880,743
Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI

Infection resistant surface for ventricular assist device (VAD) transcutaneous dr

$880,733
Patrick Thomas Cahalan · Ension, Inc. · R44 · FY2014 · HL

Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens

$880,606
Daniel E Kahne · Harvard Medical School · U19 · FY2017 · AI

Novel pre-coital, non-hormonal multipurpose prevention technology (MPT)

$880,230
Pavimol Angsantikul · Population Council · R01 · FY2022 · AI

Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia

$880,000
Scott E. Evans · University Of Tx Md Anderson Can Ctr · R35 · FY2023 · HL

Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia

$880,000
Scott E. Evans · University Of Tx Md Anderson Can Ctr · R35 · FY2021 · HL

Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia

$880,000
Scott E. Evans · University Of Tx Md Anderson Can Ctr · R35 · FY2022 · HL

Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia

$880,000
Scott E. Evans · University Of Tx Md Anderson Can Ctr · R35 · FY2025 · HL

Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia

$880,000
Scott E. Evans · University Of Tx Md Anderson Can Ctr · R35 · FY2020 · HL

Structure, function, and regulation of the bacterial transcription cycle

$879,598
Seth A Darst · Rockefeller University · R35 · FY2019 · GM

Endolysins as tools to eradicate pneumococcal biofilms and development ofprotective immunity

$879,588
Norberto Gonzalez-Juarbe · Univ Of Maryland, College Park · R01 · FY2025 · AI

Improving Quality of Care for the Treatment of Childhood Pneumonia

$879,558
Patricia L Hibberd · Massachusetts General Hospital · U01 · FY2012 · HD